ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

Ontak Approved For Lymphoma

October 31, 2008

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

In Brief: Owens New President Of AACI, Yates President Elect; UNC Gains Comprehensive Center Status

June 29, 1990

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986